Original Article

Matted nodes: Poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status†

  1. Matthew E. Spector MD1,
  2. K. Kelly Gallagher MD1,
  3. Emily Light MS2,
  4. Mohannad Ibrahim MD3,
  5. Eric J. Chanowski BS1,
  6. Jeffrey S. Moyer MD1,
  7. Mark E. Prince MD1,
  8. Gregory T. Wolf MD1,
  9. Carol R. Bradford MD1,
  10. Kitrina Cordell DDS, MS1,
  11. Jonathan B. McHugh MD4,
  12. Thomas Carey PhD1,
  13. Francis P. Worden MD5,
  14. Avraham Eisbruch MD6,
  15. Douglas B. Chepeha MD, MSPH1,*,
  16. The University of Michigan Head Neck Specialized Program of Research Excellence (SPORE) Program1

Article first published online: 13 JAN 2012

DOI: 10.1002/hed.21997

Issue

Head & Neck

Head & Neck

Volume 34, Issue 12, pages 1727–1733, December 2012

Additional Information

How to Cite

Spector, M. E., Gallagher, K. K., Light, E., Ibrahim, M., Chanowski, E. J., Moyer, J. S., Prince, M. E., Wolf, G. T., Bradford, C. R., Cordell, K., McHugh, J. B., Carey, T., Worden, F. P., Eisbruch, A., Chepeha, D. B. and The University of Michigan Head Neck Specialized Program of Research Excellence (SPORE) Program (2012), Matted nodes: Poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status. Head Neck, 34: 1727–1733. doi: 10.1002/hed.21997

Author Information

  1. 1

    Departments of Otolaryngology – Head and Neck Surgery, University of Michigan Health System, Ann Arbor, Michigan

  2. 2

    Department of Biostatistics, University of Michigan Health System, Ann Arbor, Michigan

  3. 3

    Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan

  4. 4

    Department of Pathology, University of Michigan Health System, Ann Arbor, Michigan

  5. 5

    Department of Medical Oncology, University of Michigan Health System, Ann Arbor, Michigan

  6. 6

    Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, Michigan

*Departments of Otolaryngology – Head and Neck Surgery, University of Michigan Health System, Ann Arbor, Michigan

  1. †

    This work was presented at the American Head and Neck Society Research Workshop, Arlington, Virginia, October 2010.

Publication History

  1. Issue published online: 17 NOV 2012
  2. Article first published online: 13 JAN 2012
  3. Manuscript Accepted: 13 SEP 2011

Funded by

  • P50 CA97248 National Institutes of Health (NIH) National Cancer Institute (NCI) NIDCR Specialized Program of Research Excellence (SPORE), SPORE in Head and Neck Cancer – The Molecular Basis of Head and Neck Cancer Therapy, PI: Gregory Wolf, MD

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (424K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Get PDF (424K)